These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 21234284)

  • 1. Glutaminase: a hot spot for regulation of cancer cell metabolism?
    Erickson JW; Cerione RA
    Oncotarget; 2010 Dec; 1(8):734-40. PubMed ID: 21234284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.
    Wang JB; Erickson JW; Fuji R; Ramachandran S; Gao P; Dinavahi R; Wilson KF; Ambrosio AL; Dias SM; Dang CV; Cerione RA
    Cancer Cell; 2010 Sep; 18(3):207-19. PubMed ID: 20832749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho GTPases and their roles in cancer metabolism.
    Wilson KF; Erickson JW; Antonyak MA; Cerione RA
    Trends Mol Med; 2013 Feb; 19(2):74-82. PubMed ID: 23219172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy.
    Lukey MJ; Greene KS; Erickson JW; Wilson KF; Cerione RA
    Nat Commun; 2016 Apr; 7():11321. PubMed ID: 27089238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies impacting cancer cell glutamine metabolism.
    Lukey MJ; Wilson KF; Cerione RA
    Future Med Chem; 2013 Sep; 5(14):1685-700. PubMed ID: 24047273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer.
    Udupa S; Nguyen S; Hoang G; Nguyen T; Quinones A; Pham K; Asaka R; Nguyen K; Zhang C; Elgogary A; Jung JG; Xu Q; Fu J; Thomas AG; Tsukamoto T; Hanes J; Slusher BS; Cooper AJL; Le A
    Proteomics; 2019 Nov; 19(21-22):e1800451. PubMed ID: 31231915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.
    Chen L; Cui H
    Int J Mol Sci; 2015 Sep; 16(9):22830-55. PubMed ID: 26402672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer.
    Matés JM; Di Paola FJ; Campos-Sandoval JA; Mazurek S; Márquez J
    Semin Cell Dev Biol; 2020 Feb; 98():34-43. PubMed ID: 31100352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation.
    Katt WP; Ramachandran S; Erickson JW; Cerione RA
    Mol Cancer Ther; 2012 Jun; 11(6):1269-78. PubMed ID: 22496480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis.
    Katt WP; Lukey MJ; Cerione RA
    Future Med Chem; 2017 Jan; 9(2):223-243. PubMed ID: 28111979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the molecular mechanisms of glutaminase C inhibitors in cancer cells using serial room temperature crystallography.
    Milano SK; Huang Q; Nguyen TT; Ramachandran S; Finke A; Kriksunov I; Schuller DJ; Szebenyi DM; Arenholz E; McDermott LA; Sukumar N; Cerione RA; Katt WP
    J Biol Chem; 2022 Feb; 298(2):101535. PubMed ID: 34954143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch.
    Lee SY; Jeon HM; Ju MK; Jeong EK; Kim CH; Park HG; Han SI; Kang HS
    Oncotarget; 2016 Feb; 7(7):7925-39. PubMed ID: 26771232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer metabolism: key players in metabolic reprogramming.
    Soga T
    Cancer Sci; 2013 Mar; 104(3):275-81. PubMed ID: 23279446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic targeting of malignant tumors: small-molecule inhibitors of bioenergetic flux.
    Mathupala SP
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):6-14. PubMed ID: 21110820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of transcription and activity of Rhizobium etli glutaminase A.
    Huerta-Saquero A; Calderón-Flores A; Díaz-Villaseñor A; Du Pont G; Durán S
    Biochim Biophys Acta; 2004 Aug; 1673(3):201-7. PubMed ID: 15279892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth.
    Reckzeh ES; Karageorgis G; Schwalfenberg M; Ceballos J; Nowacki J; Stroet MCM; Binici A; Knauer L; Brand S; Choidas A; Strohmann C; Ziegler S; Waldmann H
    Cell Chem Biol; 2019 Sep; 26(9):1214-1228.e25. PubMed ID: 31303578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutaminase regulation in cancer cells: a druggable chain of events.
    Katt WP; Cerione RA
    Drug Discov Today; 2014 Apr; 19(4):450-7. PubMed ID: 24140288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.
    Tanaka K; Sasayama T; Irino Y; Takata K; Nagashima H; Satoh N; Kyotani K; Mizowaki T; Imahori T; Ejima Y; Masui K; Gini B; Yang H; Hosoda K; Sasaki R; Mischel PS; Kohmura E
    J Clin Invest; 2015 Apr; 125(4):1591-602. PubMed ID: 25798620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.
    Pusapati RV; Daemen A; Wilson C; Sandoval W; Gao M; Haley B; Baudy AR; Hatzivassiliou G; Evangelista M; Settleman J
    Cancer Cell; 2016 Apr; 29(4):548-562. PubMed ID: 27052953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC-induced cancer cell energy metabolism and therapeutic opportunities.
    Dang CV; Le A; Gao P
    Clin Cancer Res; 2009 Nov; 15(21):6479-83. PubMed ID: 19861459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.